182 related articles for article (PubMed ID: 19747936)
1. Economic evaluation of skin cancer prevention in Australia.
Shih ST; Carter R; Sinclair C; Mihalopoulos C; Vos T
Prev Med; 2009 Nov; 49(5):449-53. PubMed ID: 19747936
[TBL] [Abstract][Full Text] [Related]
2. The Australian experience in sun protection and screening for melanoma.
McCarthy WH
J Surg Oncol; 2004 Jul; 86(4):236-45. PubMed ID: 15221930
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children.
Kyle JW; Hammitt JK; Lim HW; Geller AC; Hall-Jordan LH; Maibach EW; De Fabo EC; Wagner MC
Pediatrics; 2008 May; 121(5):e1074-84. PubMed ID: 18450850
[TBL] [Abstract][Full Text] [Related]
4. Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia.
Doran CM; Ling R; Byrnes J; Crane M; Shakeshaft AP; Searles A; Perez D
PLoS One; 2016; 11(1):e0147665. PubMed ID: 26824695
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
6. Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure.
Pil L; Hoorens I; Vossaert K; Kruse V; Tromme I; Speybroeck N; Brochez L; Annemans L
Prev Med; 2016 Dec; 93():177-182. PubMed ID: 27713103
[TBL] [Abstract][Full Text] [Related]
7. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy.
Ess SM; Szucs TD
Ital Heart J; 2001 Mar; 2(3):181-8. PubMed ID: 11305529
[TBL] [Abstract][Full Text] [Related]
8. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?
Anderson R; Haas M; Shanahan M
Aust N Z J Public Health; 2008 Feb; 32(1):43-52. PubMed ID: 18290913
[TBL] [Abstract][Full Text] [Related]
11. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005.
Goldberg MS; Doucette JT; Lim HW; Spencer J; Carucci JA; Rigel DS
J Am Acad Dermatol; 2007 Jul; 57(1):60-6. PubMed ID: 17490783
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme.
Gordon L; Youl PH; Elwood M; Janda M; Ring IT; Lowe JB; Aitken JF
J Med Screen; 2007; 14(2):98-102. PubMed ID: 17626710
[TBL] [Abstract][Full Text] [Related]
14. Using an economic model of diabetes to evaluate prevention and care strategies in Australia.
Colagiuri S; Walker AE
Health Aff (Millwood); 2008; 27(1):256-68. PubMed ID: 18180502
[TBL] [Abstract][Full Text] [Related]
15. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.
Harris A; Hendrie D; Bower C; Payne J; de Klerk N; Stanley F
Med J Aust; 1994 Apr; 160(8):483-8. PubMed ID: 8170423
[TBL] [Abstract][Full Text] [Related]
16. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
[TBL] [Abstract][Full Text] [Related]
17. [1989 Bochum health education program for malignant melanoma].
Hoffmann K; Matthes U; Stücker M; Segerling M; Altmeyer P
Offentl Gesundheitswes; 1990 Jan; 52(1):9-13. PubMed ID: 2138274
[TBL] [Abstract][Full Text] [Related]
18. Melanoma death prevention: moving away from the sun.
Mitchell JK; Leslie KS
J Am Acad Dermatol; 2013 Jun; 68(6):e169-75. PubMed ID: 23545369
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of cutaneous melanoma].
van der Rhee HJ; Coebergh JW
Ned Tijdschr Geneeskd; 1999 Jun; 143(26):1356-9. PubMed ID: 10416492
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
